Marshall Wace LLP Lowers Stock Position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA)
Marshall Wace LLP reduced its position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 71.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 138,111 shares of the company’s stock after selling 347,915 shares during the period. Marshall Wace LLP’s holdings in Taysha Gene Therapies were worth $239,000 at the end of […]
Marshall Wace LLP reduced its position in Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Free Report) by 71.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 138,111 shares of the company’s stock after selling 347,915 shares during the period. Marshall Wace LLP’s holdings in Taysha Gene Therapies were worth $239,000 at the end of […]
